Nanomedical Diagnostics

Cardea (formerly known Nanomed) is a medtech company developing graphene biosensors, tools for small molecule drug discovery and development. It offers an electrical assay based on proprietary Field Effect Biosensing (FEB) technology that detects molecular interactions without the use of optics or labeling. This technology delivers sensitive label-free binding confirmation of biomolecular interactions for accelerated drug discovery.